LFA-based Cardiac Industry Research Report 2023

LFA-based Cardiac Industry Research Report 2023


Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.

Highlights

The global LFA-based Cardiac market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech

Product Type Insights

Global markets are presented by LFA-based Cardiac type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the LFA-based Cardiac are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
LFA-based Cardiac segment by Type

Troponin I
Troponin T
CK-MB
Myoglobin
Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the LFA-based Cardiac market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the LFA-based Cardiac market.
LFA-based Cardiac Segment by Application

Laboratory Testing
Point-of-care Testing

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the LFA-based Cardiac market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global LFA-based Cardiac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of LFA-based Cardiac and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the LFA-based Cardiac industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of LFA-based Cardiac.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of LFA-based Cardiac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 LFA-based Cardiac by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
2.3 LFA-based Cardiac by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Laboratory Testing
2.3.3 Point-of-care Testing
2.4 Assumptions and Limitations
3 LFA-based Cardiac Breakdown Data by Type
3.1 Global LFA-based Cardiac Historic Market Size by Type (2018-2023)
3.2 Global LFA-based Cardiac Forecasted Market Size by Type (2023-2028)
4 LFA-based Cardiac Breakdown Data by Application
4.1 Global LFA-based Cardiac Historic Market Size by Application (2018-2023)
4.2 Global LFA-based Cardiac Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global LFA-based Cardiac Market Perspective (2018-2029)
5.2 Global LFA-based Cardiac Growth Trends by Region
5.2.1 Global LFA-based Cardiac Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 LFA-based Cardiac Historic Market Size by Region (2018-2023)
5.2.3 LFA-based Cardiac Forecasted Market Size by Region (2024-2029)
5.3 LFA-based Cardiac Market Dynamics
5.3.1 LFA-based Cardiac Industry Trends
5.3.2 LFA-based Cardiac Market Drivers
5.3.3 LFA-based Cardiac Market Challenges
5.3.4 LFA-based Cardiac Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top LFA-based Cardiac Players by Revenue
6.1.1 Global Top LFA-based Cardiac Players by Revenue (2018-2023)
6.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2018-2023)
6.2 Global LFA-based Cardiac Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of LFA-based Cardiac Head office and Area Served
6.4 Global LFA-based Cardiac Players, Product Type & Application
6.5 Global LFA-based Cardiac Players, Date of Enter into This Industry
6.6 Global LFA-based Cardiac Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America LFA-based Cardiac Market Size (2018-2029)
7.2 North America LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America LFA-based Cardiac Market Size by Country (2018-2023)
7.4 North America LFA-based Cardiac Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe LFA-based Cardiac Market Size (2018-2029)
8.2 Europe LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe LFA-based Cardiac Market Size by Country (2018-2023)
8.4 Europe LFA-based Cardiac Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific LFA-based Cardiac Market Size (2018-2029)
9.2 Asia-Pacific LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific LFA-based Cardiac Market Size by Country (2018-2023)
9.4 Asia-Pacific LFA-based Cardiac Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America LFA-based Cardiac Market Size (2018-2029)
10.2 Latin America LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America LFA-based Cardiac Market Size by Country (2018-2023)
10.4 Latin America LFA-based Cardiac Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa LFA-based Cardiac Market Size (2018-2029)
11.2 Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa LFA-based Cardiac Market Size by Country (2018-2023)
11.4 Middle East & Africa LFA-based Cardiac Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche LFA-based Cardiac Introduction
11.1.4 Roche Revenue in LFA-based Cardiac Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott LFA-based Cardiac Introduction
11.2.4 Abbott Revenue in LFA-based Cardiac Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens LFA-based Cardiac Introduction
11.3.4 Siemens Revenue in LFA-based Cardiac Business (2017-2022)
11.3.5 Siemens Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher LFA-based Cardiac Introduction
11.4.4 Danaher Revenue in LFA-based Cardiac Business (2017-2022)
11.4.5 Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction
11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2017-2022)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Detail
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux LFA-based Cardiac Introduction
11.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2017-2022)
11.6.5 BioMérieux Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher LFA-based Cardiac Introduction
11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2017-2022)
11.7.5 Thermo Fisher Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2017-2022)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 LSI Medience Corporation
11.9.1 LSI Medience Corporation Company Detail
11.9.2 LSI Medience Corporation Business Overview
11.9.3 LSI Medience Corporation LFA-based Cardiac Introduction
11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2017-2022)
11.9.5 LSI Medience Corporation Recent Development
11.10 Randox laboratories
11.10.1 Randox laboratories Company Detail
11.10.2 Randox laboratories Business Overview
11.10.3 Randox laboratories LFA-based Cardiac Introduction
11.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2017-2022)
11.10.5 Randox laboratories Recent Development
11.11 Wondfo Biotech
11.11.1 Wondfo Biotech Company Detail
11.11.2 Wondfo Biotech Business Overview
11.11.3 Wondfo Biotech LFA-based Cardiac Introduction
11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2017-2022)
11.11.5 Wondfo Biotech Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global LFA-based Cardiac Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global LFA-based Cardiac Revenue Market Share by Type (2018-2023)
Table 7. Global LFA-based Cardiac Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global LFA-based Cardiac Revenue Market Share by Type (2024-2029)
Table 9. Global LFA-based Cardiac Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global LFA-based Cardiac Revenue Market Share by Application (2018-2023)
Table 11. Global LFA-based Cardiac Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global LFA-based Cardiac Revenue Market Share by Application (2024-2029)
Table 13. Global LFA-based Cardiac Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global LFA-based Cardiac Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global LFA-based Cardiac Market Share by Region (2018-2023)
Table 16. Global LFA-based Cardiac Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global LFA-based Cardiac Market Share by Region (2024-2029)
Table 18. LFA-based Cardiac Market Trends
Table 19. LFA-based Cardiac Market Drivers
Table 20. LFA-based Cardiac Market Challenges
Table 21. LFA-based Cardiac Market Restraints
Table 22. Global Top LFA-based Cardiac Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global LFA-based Cardiac Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global LFA-based Cardiac Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of LFA-based Cardiac, Headquarters and Area Served
Table 26. Global LFA-based Cardiac Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global LFA-based Cardiac by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America LFA-based Cardiac Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America LFA-based Cardiac Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe LFA-based Cardiac Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe LFA-based Cardiac Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific LFA-based Cardiac Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific LFA-based Cardiac Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America LFA-based Cardiac Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America LFA-based Cardiac Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa LFA-based Cardiac Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa LFA-based Cardiac Market Size by Country (2024-2029) & (US$ Million)
Table 45. Roche Company Detail
Table 46. Roche Business Overview
Table 47. Roche LFA-based Cardiac Product
Table 48. Roche Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott LFA-based Cardiac Product
Table 53. Abbott Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Siemens Company Detail
Table 56. Siemens Business Overview
Table 57. Siemens LFA-based Cardiac Product
Table 58. Siemens Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 59. Siemens Recent Development
Table 60. Danaher Company Detail
Table 61. Danaher Business Overview
Table 62. Danaher LFA-based Cardiac Product
Table 63. Danaher Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 64. Danaher Recent Development
Table 65. Bio-Rad Laboratories Company Detail
Table 66. Bio-Rad Laboratories Business Overview
Table 67. Bio-Rad Laboratories LFA-based Cardiac Product
Table 68. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 69. Bio-Rad Laboratories Recent Development
Table 70. BioMérieux Company Detail
Table 71. BioMérieux Business Overview
Table 72. BioMérieux LFA-based Cardiac Product
Table 73. BioMérieux Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 74. BioMérieux Recent Development
Table 75. Thermo Fisher Company Detail
Table 76. Thermo Fisher Business Overview
Table 77. Thermo Fisher LFA-based Cardiac Product
Table 78. Thermo Fisher Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 79. Thermo Fisher Recent Development
Table 80. Ortho Clinical Diagnostics Company Detail
Table 81. Ortho Clinical Diagnostics Business Overview
Table 82. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 83. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 84. Ortho Clinical Diagnostics Recent Development
Table 85. LSI Medience Corporation Company Detail
Table 86. LSI Medience Corporation Business Overview
Table 87. LSI Medience Corporation LFA-based Cardiac Product
Table 88. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 89. LSI Medience Corporation Recent Development
Table 90. Randox laboratories Company Detail
Table 91. Randox laboratories Business Overview
Table 92. Randox laboratories LFA-based Cardiac Product
Table 93. Randox laboratories Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 94. Randox laboratories Recent Development
Table 95. Wondfo Biotech Company Detail
Table 96. Wondfo Biotech Business Overview
Table 97. Wondfo Biotech LFA-based CardiacProduct
Table 98. Wondfo Biotech Revenue in LFA-based Cardiac Business (2017-2022) & (US$ Million)
Table 99. Wondfo Biotech Recent Development
Table 100. Roche Company Information
Table 101. Roche Business Overview
Table 102. Roche LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 103. Roche Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 104. Roche Recent Development
Table 105. Abbott Company Information
Table 106. Abbott Business Overview
Table 107. Abbott LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 108. Abbott Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 109. Abbott Recent Development
Table 110. Siemens Company Information
Table 111. Siemens Business Overview
Table 112. Siemens LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 113. Siemens Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 114. Siemens Recent Development
Table 115. Danaher Company Information
Table 116. Danaher Business Overview
Table 117. Danaher LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 118. Danaher Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 119. Danaher Recent Development
Table 120. Bio-Rad Laboratories Company Information
Table 121. Bio-Rad Laboratories Business Overview
Table 122. Bio-Rad Laboratories LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 123. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 124. Bio-Rad Laboratories Recent Development
Table 125. BioMérieux Company Information
Table 126. BioMérieux Business Overview
Table 127. BioMérieux LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 128. BioMérieux Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 129. BioMérieux Recent Development
Table 130. Thermo Fisher Company Information
Table 131. Thermo Fisher Business Overview
Table 132. Thermo Fisher LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 133. Thermo Fisher Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 134. Thermo Fisher Recent Development
Table 135. Ortho Clinical Diagnostics Company Information
Table 136. Ortho Clinical Diagnostics Business Overview
Table 137. Ortho Clinical Diagnostics LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 138. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 139. Ortho Clinical Diagnostics Recent Development
Table 140. LSI Medience Corporation Company Information
Table 141. LSI Medience Corporation Business Overview
Table 142. LSI Medience Corporation LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 143. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 144. LSI Medience Corporation Recent Development
Table 145. Randox laboratories Company Information
Table 146. Randox laboratories Business Overview
Table 147. Randox laboratories LFA-based Cardiac Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 148. Randox laboratories Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 149. Randox laboratories Recent Development
Table 150. Wondfo Biotech Company Information
Table 151. Wondfo Biotech Business Overview
Table 152. Wondfo Biotech LFA-based CardiacRevenue in LFA-based Cardiac Business (2018-2023) & (US$ Million)
Table 153. Wondfo Biotech Revenue in LFA-based Cardiac Business (2018-2023) & (US$ Million) Portfolio
Table 154. Wondfo Biotech Recent Development
Table 155. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. LFA-based Cardiac Product Picture
Figure 5. Global LFA-based Cardiac Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global LFA-based Cardiac Market Share by Type: 2022 VS 2029
Figure 7. Troponin I Product Picture
Figure 8. Troponin T Product Picture
Figure 9. CK-MB Product Picture
Figure 10. Myoglobin Product Picture
Figure 11. Others Product Picture
Figure 12. Global LFA-based Cardiac Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global LFA-based Cardiac Market Share by Application: 2022 VS 2029
Figure 14. Laboratory Testing Product Picture
Figure 15. Point-of-care Testing Product Picture
Figure 16. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global LFA-based Cardiac Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global LFA-based Cardiac Market Share by Region: 2022 VS 2029
Figure 19. Global LFA-based Cardiac Market Share by Players in 2022
Figure 20. Global LFA-based Cardiac Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 LFA-based Cardiac Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America LFA-based Cardiac Market Share by Country (2018-2029)
Figure 25. United States LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe LFA-based Cardiac Market Share by Country (2018-2029)
Figure 29. Germany LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific LFA-based Cardiac Market Share by Country (2018-2029)
Figure 37. China LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America LFA-based Cardiac Market Share by Country (2018-2029)
Figure 45. Mexico LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa LFA-based Cardiac Market Share by Country (2018-2029)
Figure 49. Turkey LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE LFA-based Cardiac Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Roche Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 54. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 55. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 57. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 58. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 59. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 60. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 61. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)
Figure 62. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings